VSee Health, Inc. Revenue from Contract with Customer, Excluding Assessed Tax
VSee Health, Inc. (VSEE) reported Revenue from Contract with Customer, Excluding Assessed Tax of $1.56 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-14
- VSee Health, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $1.56M, a 48.02% increase year-over-year.
- VSee Health, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $3.16M, a 4.86% decline year-over-year.
- VSee Health, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $3.93M, a 5.13% increase year-over-year.
- VSee Health, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $3.98M, a 18.67% increase year-over-year.
- VSee Health, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $14.62M, a 40.27% increase from fiscal 2024.
- VSee Health, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $10.42M, a 80.74% increase from fiscal 2023.
- VSee Health, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $5.77M.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 3 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.56M 10-Q · filed 2026-08-14 | $3.44M 10-Q · filed 2026-08-14 | $8.65M derived: sum of 3 quarters · filed 2026-08-14 | $12.63M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | $3.16M 10-Q · filed 2026-05-15 | $7.09M derived: sum of 2 quarters · filed 2026-05-15 | $11.07M derived: sum of 3 quarters · filed 2026-05-15 | $12.12M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | $3.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $7.91M derived: sum of 2 quarters · filed 2026-03-31 | $8.96M derived: sum of 3 quarters · filed 2026-08-14 | $14.62M 10-K · filed 2026-03-31 | |||
| 2025-09-30 | $3.98M 10-Q · filed 2025-11-14 | $5.04M derived: sum of 2 quarters · filed 2026-08-14 | $10.69M 10-Q · filed 2025-11-14 | $12.09M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | $1.06M 10-Q · filed 2026-08-14 | $3.39M 10-Q · filed 2025-10-15 | $2.25M 10-Q · filed 2026-08-14 | $6.71M 10-Q · filed 2025-10-15 | $8.11M derived: sum of 3 quarters · filed 2026-08-14 | $11.47M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $3.32M 10-Q · filed 2026-05-15 | $7.06M derived: sum of 2 quarters · filed 2026-05-15 | $10.41M derived: sum of 3 quarters · filed 2026-05-15 | $12.12M derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | $3.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $7.09M derived: sum of 2 quarters · filed 2026-03-31 | $8.80M derived: sum of 3 quarters · filed 2026-03-31 | $10.42M 10-K · filed 2026-03-31 | |||
| 2024-09-30 | $3.35M 10-Q · filed 2025-11-14 | $5.07M derived: sum of 2 quarters · filed 2025-11-20 | $6.69M 10-Q · filed 2025-11-14 | $6.56M 10-Q · filed 2024-11-14 | $8.17M derived: sum of 4 quarters · filed 2025-11-20 | ||
| 2024-06-30 | $1.71M 10-Q/A · filed 2025-11-20 | $3.33M 10-Q/A · filed 2025-11-20 | $3.21M 10-Q · filed 2024-09-23 | $4.82M derived: sum of 3 quarters · filed 2025-11-20 | $6.25M derived: sum of 4 quarters · filed 2025-11-20 | ||
| 2024-03-31 | $1.62M 10-Q · filed 2025-10-15 | $3.11M derived: sum of 2 quarters · filed 2025-10-15 | $4.54M derived: sum of 3 quarters · filed 2025-10-15 | $5.81M derived: sum of 4 quarters · filed 2025-10-15 | |||
| 2023-12-31 | $1.48M derived: 10-K/A 12 month − 10-K/A 9 month · filed 2025-08-29 | $2.92M derived: sum of 2 quarters · filed 2025-08-29 | $4.19M derived: sum of 3 quarters · filed 2025-08-29 | $5.77M 10-K/A · filed 2025-08-29 | |||
| 2023-09-30 | $1.43M 10-K/A · filed 2025-08-29 | $1.45M 10-Q · filed 2024-11-14 | $2.70M derived: sum of 2 quarters · filed 2025-08-29 | $4.28M 10-K/A · filed 2025-08-29 | $4.34M 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $1.27M 10-K/A · filed 2025-08-29 | $1.29M 10-Q · filed 2024-09-23 | $2.85M 10-K/A · filed 2025-08-29 | $2.89M 10-Q · filed 2024-09-23 | |||
| 2023-03-31 | $1.58M 10-K/A · filed 2025-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |